Pathway Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Pathway Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-245,606	Closed	-$3.67M	–	9
2022 Q4	$3.67M	Buy	+245,606	New	+$3.4M	6.55%	4

Pathway Capital Management's AVEO Position: Q1 2023 in Review

Pathway Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 245,606 shares — an estimated $3.67M sold.

Pathway Capital Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $3.67M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Pathway Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Pathway Capital Management sold 245,606 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $3.67M.
Pathway Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Pathway Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $3.67M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Pathway Capital Management's 13F filing for Q1 2023, filed 10 May 2023.